174 related articles for article (PubMed ID: 33766724)
1. Is Improved Survival in Early-Stage Pancreatic Cancer Worth the Extra Cost at High-Volume Centers?
Perry LM; Bateni SB; Bold RJ; Hoch JS
J Am Coll Surg; 2021 Jul; 233(1):90-98. PubMed ID: 33766724
[TBL] [Abstract][Full Text] [Related]
2. Defining Value for Pancreatic Surgery in Early-Stage Pancreatic Cancer.
Bateni SB; Gingrich AA; Hoch JS; Canter RJ; Bold RJ
JAMA Surg; 2019 Oct; 154(10):e193019. PubMed ID: 31433465
[TBL] [Abstract][Full Text] [Related]
3. Drivers of Cost for Pancreatic Surgery: It's Not About Hospital Volume.
Bateni SB; Olson JL; Hoch JS; Canter RJ; Bold RJ
Ann Surg Oncol; 2018 Dec; 25(13):3804-3811. PubMed ID: 30218244
[TBL] [Abstract][Full Text] [Related]
4. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
[TBL] [Abstract][Full Text] [Related]
5. Centralization of Pancreatic Surgery Improves Results: Review.
Ahola R; Sand J; Laukkarinen J
Scand J Surg; 2020 Mar; 109(1):4-10. PubMed ID: 31969066
[TBL] [Abstract][Full Text] [Related]
6. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers.
Lidsky ME; Sun Z; Nussbaum DP; Adam MA; Speicher PJ; Blazer DG
Ann Surg; 2017 Aug; 266(2):333-338. PubMed ID: 27429020
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.
Ljungman D; Lundholm K; Hyltander A
World J Surg; 2011 Mar; 35(3):662-70. PubMed ID: 21132294
[TBL] [Abstract][Full Text] [Related]
8. Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy.
Balzano G; Capretti G; Callea G; Cantù E; Carle F; Pezzilli R
HPB (Oxford); 2016 May; 18(5):470-8. PubMed ID: 27154812
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness after a pancreaticoduodenectomy: bolstering the volume argument.
Sutton JM; Wilson GC; Paquette IM; Wima K; Hanseman DJ; Quillin RC; Sussman JJ; Edwards MJ; Ahmad SA; Shah SA; Abbott DE
HPB (Oxford); 2014 Dec; 16(12):1056-61. PubMed ID: 25041104
[TBL] [Abstract][Full Text] [Related]
10. Readmission After Pancreaticoduodenectomy: The Influence of the Volume Effect Beyond Mortality.
Sutton JM; Wilson GC; Wima K; Hoehn RS; Cutler Quillin R; Hanseman DJ; Paquette IM; Sussman JJ; Ahmad SA; Shah SA; Abbott DE
Ann Surg Oncol; 2015 Nov; 22(12):3785-92. PubMed ID: 25840560
[TBL] [Abstract][Full Text] [Related]
11. Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer.
Gani F; Johnston FM; Nelson-Williams H; Cerullo M; Dillhoff ME; Schmidt CR; Pawlik TM
J Gastrointest Surg; 2017 Sep; 21(9):1411-1419. PubMed ID: 28664254
[TBL] [Abstract][Full Text] [Related]
12. Trends and disparities in regionalization of pancreatic resection.
Riall TS; Eschbach KA; Townsend CM; Nealon WH; Freeman JL; Goodwin JS
J Gastrointest Surg; 2007 Oct; 11(10):1242-51; discussion 1251-2. PubMed ID: 17694419
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Care: Impact of Socioeconomic Factors on Pancreatic Surgery: Exploring the National Cancer Database.
Makar M; Worple E; Dove J; Hunsinger M; Arora T; Oxenberg J; Blansfield JA
Am Surg; 2019 Apr; 85(4):327-334. PubMed ID: 31043190
[TBL] [Abstract][Full Text] [Related]
14. Cost of Major Complications After Liver Resection in the United States: Are High-volume Centers Cost-effective?
Idrees JJ; Johnston FM; Canner JK; Dillhoff M; Schmidt C; Haut ER; Pawlik TM
Ann Surg; 2019 Mar; 269(3):503-510. PubMed ID: 29232212
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement.
Abbott DE; Merkow RP; Cantor SB; Fleming JB; Varadhachary GR; Crane C; Bentrem DJ; Bilimoria KY
Ann Surg Oncol; 2012 Nov; 19(12):3659-67. PubMed ID: 22965567
[TBL] [Abstract][Full Text] [Related]
16. Elderly Patients Strongly Benefit from Centralization of Pancreatic Cancer Surgery: A Population-Based Study.
van der Geest LG; Besselink MG; Busch OR; de Hingh IH; van Eijck CH; Dejong CH; Lemmens VE
Ann Surg Oncol; 2016 Jun; 23(6):2002-9. PubMed ID: 26795767
[TBL] [Abstract][Full Text] [Related]
17. Textbook oncologic outcome in pancreaticoduodenectomy: Do regionalization efforts make sense?
Kulshrestha S; Sweigert PJ; Tonelli C; Bunn C; Luchette FA; Abdelsattar ZM; Pawlik TM; Baker MS
J Surg Oncol; 2022 Mar; 125(3):414-424. PubMed ID: 34617590
[TBL] [Abstract][Full Text] [Related]
18. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
[TBL] [Abstract][Full Text] [Related]
19. An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions?
Tran TB; Dua MM; Worhunsky DJ; Poultsides GA; Norton JA; Visser BC
Am J Surg; 2016 Jun; 211(6):991-997.e1. PubMed ID: 26902956
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic resections are not only safest but also most cost-effective when performed in a high-volume centre: A Finnish register study.
Ahola R; Sand J; Laukkarinen J
Pancreatology; 2019 Jul; 19(5):769-774. PubMed ID: 31239104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
